{"id":53236,"date":"2023-01-24T16:02:40","date_gmt":"2023-01-24T15:02:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/"},"modified":"2023-01-24T16:02:40","modified_gmt":"2023-01-24T15:02:40","slug":"data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/","title":{"rendered":"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Annual industry report by eClinical Solutions uncovers clinical data pain points and priorities for global life science leaders<\/i>\n<\/p>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.eclinicalsol.com%2F&amp;esheet=53289380&amp;newsitemid=20230124005276&amp;lan=en-US&amp;anchor=eClinical+Solutions&amp;index=1&amp;md5=98a1ea5f800a7f163c3ada4d29f6588f\" rel=\"nofollow noopener\" shape=\"rect\">eClinical Solutions<\/a>, a global provider of digital clinical software and biometrics services, today announced the results from its <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.eclinicalsol.com%2Febooks%2Fclinical-data-trends-challenges-and-opportunities%2F&amp;esheet=53289380&amp;newsitemid=20230124005276&amp;lan=en-US&amp;anchor=2023+Industry+Outlook%2C+an+inaugural+annual+report&amp;index=2&amp;md5=0762229ba3dfb67c84304f2f5f24768c\" rel=\"nofollow noopener\" shape=\"rect\">2023 Industry Outlook, an inaugural annual report<\/a>. Based on research with 60 biopharmaceutical clinical operations and biometrics professionals, the report reveals exclusive insights on the most pressing trends, challenges, and opportunities shaping the fast-moving clinical data landscape.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/5\/Survey_Book_Figure_4.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/21\/Survey_Book_Figure_4.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693498\/5\/eClinical-Solutions_Large.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693498\/21\/eClinical-Solutions_Large.jpg\"><\/a><\/p>\n<p>\nTop-line highlights include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n64% of respondents report that their organizations are incorporating six or more external data sources into their clinical trials.\n<\/li>\n<li>\nHarnessing automation throughout the clinical data lifecycle is currently the top industry focus for more than one-third (36%) of respondents.\n<\/li>\n<li>\nAccording to respondents, speed (30%) and quality (30%) remain the largest pain points for Study Build and Electronic Data Capture (EDC) implementation.\n<\/li>\n<li>\nHalf of respondents report either the variety of data types (26%) or standardization (24%) as their top challenge with external data.\n<\/li>\n<\/ul>\n<p>\nCommenting on the findings, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.eclinicalsol.com%2Ftag%2FKatrina-Rice%2F&amp;esheet=53289380&amp;newsitemid=20230124005276&amp;lan=en-US&amp;anchor=Katrina+Rice&amp;index=3&amp;md5=bd5933b78e6003fcb5e10ff27dc89641\" rel=\"nofollow noopener\" shape=\"rect\">Katrina Rice<\/a>, chief delivery officer, biometrics services at eClinical Solutions said, \u201cOur 2023 Industry Outlook confirms that leaders are embracing the potential of decentralization, automation, and other tech-enabled approaches to transform clinical research while navigating the new challenges of increased trial complexity.\u201d\n<\/p>\n<p>\nThe report also confirms that data standardization, accessing the right expertise through vendor collaborations, and strategies to accelerate cycle times are major concerns for clinical leaders heading into 2023.\n<\/p>\n<p>\nRice added, \u201cIt is encouraging that the most important themes highlighted by our respondents including cycle time reduction, study start-up efficiency and nurturing people \u2014 are all areas of core focus for us at eClinical Solutions. As we look ahead in 2023, we will focus on unlocking even greater value for our customers through our unified combination of innovative clinical data technology and premier biometrics services.\u201d\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fgrant-williamson-602ab640%2F&amp;esheet=53289380&amp;newsitemid=20230124005276&amp;lan=en-US&amp;anchor=Grant+Williamson&amp;index=4&amp;md5=be2aa00e6b98a3492d015a9a98364697\" rel=\"nofollow noopener\" shape=\"rect\">Grant Williamson<\/a>, senior director, clinical programming at eClinical Solutions said, \u201cThe industry is still grappling with a host of longstanding challenges. Leaders report expertise and retention issues when working with outsourced providers, and, despite advances in technology, speed and quality remain concerns in managing study builds that support current trial complexity.\u201d\n<\/p>\n<p>\nTo address these specific EDC and study start-up challenges, eClinical Solutions offers a dedicated study build service to efficiently streamline Medidata Clinical Data Cloud database set up across multiple trials. Applying unparalleled knowledge of the Medidata platform, the eClinical Solutions team can achieve data standardization and study setup timeline savings of up to 60% for customers.\n<\/p>\n<p>\nWilliamson added, \u201cWe\u2019ve seen increased demand from clients requiring robust EDC implementations that support complex designs like basket trials and expected protocol changes after startup. In the face of increasing trial complexity, timeline pressure, and talent scarcity, sponsors appreciate having access to eClinical Solutions\u2019 highly qualified data acquisition professionals with the skills to design and execute efficient study builds across therapeutic areas and phases of development.\u201d\n<\/p>\n<p>\nTo receive a copy of the eClinical Solutions\u2019 2023 Industry Outlook report, click here: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.eclinicalsol.com%2Febooks%2Fclinical-data-trends-challenges-and-opportunities%2F&amp;esheet=53289380&amp;newsitemid=20230124005276&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.eclinicalsol.com%2Febooks%2Fclinical-data-trends-challenges-and-opportunities%2F&amp;index=5&amp;md5=66d3826edad921519b77029eabbc3c8c\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.eclinicalsol.com\/ebooks\/clinical-data-trends-challenges-and-opportunities\/<\/a>.\n<\/p>\n<p>\nFor more information on the eClinical Solutions Study Build FSP, click here: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.eclinicalsol.com%2Fservices%2Fstudy-build-functional-service-provider-fsp%2F&amp;esheet=53289380&amp;newsitemid=20230124005276&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.eclinicalsol.com%2Fservices%2Fstudy-build-functional-service-provider-fsp%2F&amp;index=6&amp;md5=fc888439d83f6441fd27def6c8d1abbd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.eclinicalsol.com\/services\/study-build-functional-service-provider-fsp\/<\/a>.\n<\/p>\n<p>\n<b>About eClinical Solutions<\/b>\n<\/p>\n<p>\neClinical Solutions helps life sciences organizations around the world accelerate their digital clinical initiatives with modern data infrastructure and analytics. Our intelligent clinical data cloud and biometrics services give our clients real-time, self-service access to all their data from one centralized location; plus advanced analytics that help them make smarter, faster business decisions. Find out more at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.eclinicalsol.com%2F&amp;esheet=53289380&amp;newsitemid=20230124005276&amp;lan=en-US&amp;anchor=eclinicalsol.com&amp;index=7&amp;md5=8126a38a204123b8555e1bd9de1a612d\" rel=\"nofollow noopener\" shape=\"rect\">eclinicalsol.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAlex Connelly<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#101;&#67;&#x6c;&#x69;&#x6e;&#x69;&#x63;&#x61;&#x6c;&#64;pan&#99;&#111;&#109;&#109;&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">e&#67;&#x6c;&#x69;n&#105;&#99;&#x61;&#x6c;&#64;&#112;&#97;&#x6e;&#x63;o&#109;&#x6d;&#x2e;&#x63;o&#109;<\/a><br \/>(401) 486-7437\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Annual industry report by eClinical Solutions uncovers clinical data pain points and priorities for global life science leaders BOSTON&#8211;(BUSINESS WIRE)&#8211;eClinical Solutions, a global provider of digital clinical software and biometrics services, today announced the results from its 2023 Industry Outlook, an inaugural annual report. Based on research with 60 biopharmaceutical clinical operations and biometrics professionals, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53236","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Annual industry report by eClinical Solutions uncovers clinical data pain points and priorities for global life science leaders BOSTON&#8211;(BUSINESS WIRE)&#8211;eClinical Solutions, a global provider of digital clinical software and biometrics services, today announced the results from its 2023 Industry Outlook, an inaugural annual report. Based on research with 60 biopharmaceutical clinical operations and biometrics professionals, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-24T15:02:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/21\/Survey_Book_Figure_4.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds\",\"datePublished\":\"2023-01-24T15:02:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/\"},\"wordCount\":582,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005276\\\/en\\\/1693504\\\/21\\\/Survey_Book_Figure_4.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/\",\"name\":\"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005276\\\/en\\\/1693504\\\/21\\\/Survey_Book_Figure_4.jpg\",\"datePublished\":\"2023-01-24T15:02:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005276\\\/en\\\/1693504\\\/21\\\/Survey_Book_Figure_4.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005276\\\/en\\\/1693504\\\/21\\\/Survey_Book_Figure_4.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/","og_locale":"en_US","og_type":"article","og_title":"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds - Pharma Trend","og_description":"Annual industry report by eClinical Solutions uncovers clinical data pain points and priorities for global life science leaders BOSTON&#8211;(BUSINESS WIRE)&#8211;eClinical Solutions, a global provider of digital clinical software and biometrics services, today announced the results from its 2023 Industry Outlook, an inaugural annual report. Based on research with 60 biopharmaceutical clinical operations and biometrics professionals, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-24T15:02:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/21\/Survey_Book_Figure_4.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds","datePublished":"2023-01-24T15:02:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/"},"wordCount":582,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/21\/Survey_Book_Figure_4.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/","url":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/","name":"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/21\/Survey_Book_Figure_4.jpg","datePublished":"2023-01-24T15:02:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/21\/Survey_Book_Figure_4.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230124005276\/en\/1693504\/21\/Survey_Book_Figure_4.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/data-variety-and-standardization-remain-top-challenges-for-biopharma-operations-new-survey-finds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Data Variety and Standardization Remain Top Challenges for Biopharma Operations, New Survey Finds"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53236"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53236\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}